Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease.
We tested blood samples of 25 pediatric renal transplant recipients for Epstein-Barr virus (EBV) DNA load by quantitative polymerase chain reaction (PCR). Eleven of these transplant recipients showed clinical persistent mononucleosis-like symptoms years after transplantation (Tx). A quantitation of EBV DNA by PCR in peripheral blood lymphocyte (PBL) and serum samples revealed variable EBV DNA titers. The majority of EBV PCR results in samples of the 14 asymptomatic transplant recipients was repeatedly below detection limit. In contrast, patients with mononucleosis-like symptoms showed persistent EBV genome titers over a period of 6 months, ranging from 75 to 18 750 copies/10 000 PBL and from 680 to 335 000 copies/mL serum, respectively. One child suffering from this mononucleosis-like condition developed an EBV-associated Burkitt-like lymphoma 29 months after Tx. Whereas clinical and histological investigations did not indicate a post-transplant lymphoproliferative disorder (PTLD) until tumor detection, EBV titers in PBL and serum had been high for at least 8 months. We propose that pediatric transplant recipients who show both, recurrent mononucleosis-like symptoms and a sustained high EBV genome load, are at increased risk for severe EBV-related post-transplant complications.
Campe
Hartmut
H
Department of Virology, Max von Pettenkofer Institute for Hygiene and Microbiology, Ludwig-Maximilians University, Munich, Germany. campe@m3401.mpk.med.uni-muenchen.de
Jaeger
Gundula
G
Abou-Ajram
Claudia
C
Nitschko
Hans
H
Griebel
Martin
M
Montoya
Carmen
C
Klare
Bernd
B
Koszinowski
Ulrich
U
D002051:Burkitt Lymphoma / Q000175:diagnosis / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004279:DNA, Viral / Q000097:blood*; D005260:Female; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D007244:Infectious Mononucleosis / Q000175:diagnosis* / Q000209:etiology / Q000635:transmission; D016030:Kidney Transplantation / Q000009:adverse effects*; D007962:Leukocytes / Q000821:virology*; D008232:Lymphoproliferative Disorders / Q000209:etiology*; D008297:Male; D016133:Polymerase Chain Reaction; D012307:Risk Factors
D004279:DNA, Viral